The FDA is approving a generic drug for a very rare genetic disorder, but not for autism. On Tuesday, the U.S. agency said the drug helps children and adults who cannot get enough folate into ...
Debevoise & Plimpton LLP announced the launch of STAAR 2.0, an enhanced version of its award-winning* client-facing AI platform designed to help in-house legal and compliance teams evaluate, govern, ...
Surreal Hotel Arts, the São Paulo-based creative production company, has announced the opening of its first international ...
A Malaysian hospital pharmacist, Vilashini Saravanan pivoted into digital health and now works on advocating for better menopause care.
Oppenheimer 36th Annual Healthcare Life Sciences Conference February 26, 2026 12:00 PM ESTCompany ParticipantsBrett ...
Morgan Stanley Technology, Media & Telecom Conference 2026 March 3, 2026 12:15 PM ESTCompany ParticipantsEric Lefkofsky ...
Following a more than decade-long legal back-and-forth over the generic drug carveout practice known as “skinny” labeling, GSK and Teva have put their dispute to bed, new court documents show. In a ...
GSK is buying RAPT Therapeutics for US$2 billion, for access to the company’s anti-immunoglobulin E (IgE) antibody ozureprubart. The antibody, a phase II candidate, could offer a long-acting option ...
Speaking at a recent meeting of the British Pharmacological Society in Brighton, UK, Christine Mummery described how using embryonic stem cells to create human heart cells could b ...
The surge in energy prices this week is not yet enough to move European Central Bank policy from what is currently a "good place" and the bank can in any case tolerate a small overshoot of its ...
Dr. Raza Bokhari, Executive Chairman & CEO will participate in panel discussions and highlight Company’s AI-enabled Drug Development Strategy PHILADELPHIA, PA / ACCESS Newswire / March 10, 2026 / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results